Entity
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
--
e11
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum
--
--
--
csml-variable:Double
m11
0
infinite
0
--
--
e12
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum_ExtrinsicToExternalSideOfMembrane_
--
--
--
csml-variable:Double
m12
0
infinite
0
--
--
e13
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum_IntegralToMembrane_
--
--
--
csml-variable:Double
m13
0
infinite
0
--
--
e14
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulumLumen
--
--
--
csml-variable:Double
m14
0
infinite
0
--
--
e15
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum_Membrane_
--
--
--
csml-variable:Double
m15
0
infinite
0
--
--
e16
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum_ExtrinsicToInternalSideOfMembrane_
--
--
--
csml-variable:Double
m16
0
infinite
0
--
PLA2{endoplasmic reticulum}
--
e17
cso30:c:Protein
cso30:i:CC_EndoplasmicReticulum_ExtrinsicToExternalSideOfMembrane_
--
--
csml-variable:Double
m17
0
infinite
0
--
cPLA2{nuclear envelope}
--
e18
cso30:c:Protein
cso30:i:CC_NuclearEnvelopeLumen
--
csml-variable:Double
m18
0
infinite
0
--
calcium:cPLA2
--
e19
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
p42/p44MAPK{activated}
--
e20
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
cPLA2{phosphorylated}
--
e22
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m22
0
infinite
0
--
Phospholipid
--
e23
cso30:c:SmallMolecule
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m23
0
infinite
0
--
Fatty Acids (Arachidonic acid)
--
e24
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m24
0
infinite
0
--
Lysophospholipids (Lyso-PAF)
--
e25
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
csml-variable:Double
m26
0
infinite
0
--
Leukotrine A4
--
e27
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
csml-variable:Double
m28
0
infinite
0
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
csml-variable:Double
m30
0
infinite
0
--
csml-variable:Double
m31
0
infinite
0
--
Prostaglandin (PGG2)
--
e32
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m32
0
infinite
0
--
Prostaglandin (PGH2)
--
e33
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m33
0
infinite
0
--
csml-variable:Double
m34
0
infinite
0
--
csml-variable:Double
m35
0
infinite
0
--
csml-variable:Double
m36
0
infinite
0
--
csml-variable:Double
m37
0
infinite
0
--
csml-variable:Double
m38
0
infinite
0
--
M-type receptor
--
e39
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
csml-variable:Double
m40
0
infinite
0
--
Group I sPLA2:M-type receptor
--
e41
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m41
0
infinite
0
--
csml-variable:Double
m42
0
infinite
0
--
csml-variable:Double
m43
0
infinite
0
--
zymosan
--
e44
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
csml-variable:Double
m44
0
infinite
0
--
csml-variable:Double
m45
0
infinite
0
--
csml-variable:Double
m46
0
infinite
0
--
p42/p44MAPK
--
e47
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m47
0
infinite
0
--
csml-variable:Double
m48
0
infinite
0
--
csml-variable:Double
m49
0
infinite
0
--
cPLA2
--
e5
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
Calcium
--
e6
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
csml-variable:Double
m63
0
infinite
0
--
PD98059
--
e64
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m64
0
infinite
0
--
csml-variable:Double
m65
0
infinite
0
--
Okadaic acid
--
e66
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m66
0
infinite
0
--
csml-variable:Double
m67
0
infinite
0
--
csml-variable:Double
m68
0
infinite
0
--
csml-variable:Double
m69
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
csml-variable:Double
m70
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c98 : 1
stoichiometry:c6 : 1
m6*m22*0.1
nodelay
--
0
PMID: 10080535 cPLA2 is regulated by an increase in intracellular calcium, which binds to an aminoterminal C2 domain and induces its translocation to the nuclear envelope and endoplasmic reticulum.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c24 : 1
stoichiometry:c26 : 1
m27*0.1
nodelay
--
0
PMID: 10080535, 8751717 Free arachidonic acid can be metabolized by 5-lipoxygenase (5-LO) or cyclooxygenases 1 and 2 (COX1 and COX2) to generate numerous lipid mediators, such as prostaglandins (PG), leukotrienes (LT)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c30 : 1
stoichiometry:c31 : 1
m32*0.1
nodelay
--
0
PMID: 10080535, 8751717 Free arachidonic acid can be metabolized by 5-lipoxygenase (5-LO) or cyclooxygenases 1 and 2 (COX1 and COX2) to generate numerous lipid mediators, such as prostaglandins (PG), leukotrienes (LT), 8751717
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c32 : 1
stoichiometry:c33 : 1
m33*0.1
nodelay
--
0
PMID: 10080535 Free arachidonic acid can be metabolized by 5-lipoxygenase (5-LO) or cyclooxygenases 1 and 2 (COX1 and COX2) to generate numerous lipid mediators, such as prostaglandins (PG), leukotrienes (LT), 8751717
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c39 : 1
stoichiometry:c40 : 1
m40*m39*0.1
nodelay
--
0
PMID: 10080535, 8294398 group I pancreatic sPLA2 is primarily involved in the digestion of dietary lipid and may play additional roles in other tissues through its binding to M-type receptors
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c49 : 1
stoichiometry:c45 : 1
m46*m44*0.1
nodelay
--
0
PMID: 10080535, 8034717 Zymosan activates protein kinase C (PKC)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c48 : 1
stoichiometry:c103 : 1
stoichiometry:c47 : 1
m47*m45*0.1
nodelay
--
0
PMID: 10080535, 8034717 Zymosan activates protein kinase C (PKC), which initiates a kinase cascade leading to activation of p42/p44 MAPK. treatment of macrophages with the MAPK kinase (MEK) inhibitor, PD98059 together with the p38 inhibitor, SB 203580, quantitatively suppresses zymosan-induced arachidonic acid release and cPLA2 phosphorylation on S505.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c51 : 1
stoichiometry:c101 : 1
stoichiometry:c50 : 1
m48*m44*0.1
nodelay
--
0
PMID: 10080535 Zymosan also activates the MAPK homologs, Jun kinase and p38, which can phosphorylate cPLA2 in vitro and induce a gel shift, suggesting phosphorylation on S505 treatment of macrophages with the MAPK kinase (MEK) inhibitor, PD98059 together with the p38 inhibitor, SB 203580, quantitatively suppresses zymosan-induced arachidonic acid release and cPLA2 phosphorylation on S505.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c52 : 1
stoichiometry:c54 : 1
stoichiometry:c53 : 1
m63*m44*0.1
nodelay
--
0
PMID: 10080535 Zymosan also activates the MAPK homologs, Jun kinase and p38, which can phosphorylate cPLA2 in vitro and induce a gel shift, suggesting phosphorylation on S505
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c68 : 1
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c15 : 1
m23*m18*0.1
nodelay
--
0
PMID: 10080535, 9202883 PLA2 hydrolyzes phospholipid and produces lysophospholipid and fatty acid.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c69 : 1
m27*0.1
nodelay
--
0
PMID: 10080535, 8751717 Free arachidonic acid can be metabolized by 5-lipoxygenase (5-LO) or cyclooxygenases 1 and 2 (COX1 and COX2) to generate numerous lipid mediators, such as prostaglandins (PG), leukotrienes (LT)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c3 : 1
stoichiometry:c84 : 1
stoichiometry:c5 : 1
m6*m22*0.1
nodelay
--
0
PMID: 10080535 cPLA2 is regulated by an increase in intracellular calcium, which binds to an aminoterminal C2 domain and induces its translocation to the nuclear envelope and endoplasmic reticulum.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c70 : 1
m33*0.1
nodelay
--
0
PMID: 10080535 Free arachidonic acid can be metabolized by 5-lipoxygenase (5-LO) or cyclooxygenases 1 and 2 (COX1 and COX2) to generate numerous lipid mediators, such as prostaglandins (PG), leukotrienes (LT), 8751717
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c71 : 1
m33*0.1
nodelay
--
0
PMID: 10080535 Free arachidonic acid can be metabolized by 5-lipoxygenase (5-LO) or cyclooxygenases 1 and 2 (COX1 and COX2) to generate numerous lipid mediators, such as prostaglandins (PG), leukotrienes (LT), 8751717
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c72 : 1
m33*0.1
nodelay
--
0
PMID: 10080535 Free arachidonic acid can be metabolized by 5-lipoxygenase (5-LO) or cyclooxygenases 1 and 2 (COX1 and COX2) to generate numerous lipid mediators, such as prostaglandins (PG), leukotrienes (LT), 8751717
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c73 : 1
m33*0.1
nodelay
--
0
PMID: 10080535 Free arachidonic acid can be metabolized by 5-lipoxygenase (5-LO) or cyclooxygenases 1 and 2 (COX1 and COX2) to generate numerous lipid mediators, such as prostaglandins (PG), leukotrienes (LT), 8751717
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c74 : 1
stoichiometry:c75 : 1
m43*m5*0.1
nodelay
--
0
PMID: 10080535 Zymosan also activates the MAPK homologs, Jun kinase and p38, which can phosphorylate cPLA2 in vitro and induce a gel shift, suggesting phosphorylation on S505
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c78 : 1
stoichiometry:c77 : 1
m5*m49*0.1
nodelay
--
0
PMID: 10080535 Zymosan also activates the MAPK homologs, Jun kinase and p38, which can phosphorylate cPLA2 in vitro and induce a gel shift, suggesting phosphorylation on S505
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c14 : 1
stoichiometry:c95 : 1
m5*m20*0.1
nodelay
--
0
PMID: 10080535, 8227003, 8034717, 9525925 Phosphorylation of cPLA2 on S505 by mitogenactivated protein kinases (MAPK) also contributes to activation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c94 : 1
stoichiometry:c80 : 1
m66*m22*0.1
nodelay
--
0
PMID: 10080535 Treatment of Sf9 cells with A23187 induces translocation of GFP-cPLA2 but not GFP to the nuclear envelope in living Sf9 cells as observed by digital confocal microscopy. Similar results are observed using okadaic acid
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c82 : 1
stoichiometry:c88 : 1
stoichiometry:c81 : 1
m68*m22*0.1
nodelay
--
0
PMID: 10080535 Treatment of Sf9 cells with A23187 induces translocation of GFP-cPLA2 but not GFP to the nuclear envelope in living Sf9 cells as observed by digital confocal microscopy. Similar results are observed using okadaic acid
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m6*m5*0.1
nodelay
--
0
PMID: 10080535 cPLA2 is regulated by an increase in intracellular calcium, which binds to an aminoterminal C2 domain and induces its translocation to the nuclear envelope and endoplasmic reticulum.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c55 : 1
stoichiometry:c102 : 1
stoichiometry:c85 : 1
m47*m69*0.1
nodelay
--
0
PMID: 10080535, 9525925 colony-stimulating factor 1 (CSF1) is a strong MAPK activator. treatment of macrophages with the MAPK kinase (MEK) inhibitor, PD98059 together with the p38 inhibitor, SB 203580, quantitatively suppresses zymosan-induced arachidonic acid release and cPLA2 phosphorylation on S505.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c87 : 1
stoichiometry:c41 : 1
stoichiometry:c86 : 1
m48*m42*0.1
nodelay
--
0
PMID: 10080535 In human platelets, thrombin promotes phosphorylation of cPLA2 on S505 by the MAPK homolog, p38. treatment of macrophages with the MAPK kinase (MEK) inhibitor, PD98059 together with the p38 inhibitor, SB 203580, quantitatively suppresses zymosan-induced arachidonic acid release and cPLA2 phosphorylation on S505.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c93 : 1
stoichiometry:c104 : 1
stoichiometry:c90 : 1
m47*m66*0.1
nodelay
--
0
PMID: 10080535 PMA and okadaic acid are strong activators of MAPK leading to cPLA2 phosphorylation. treatment of macrophages with the MAPK kinase (MEK) inhibitor, PD98059 together with the p38 inhibitor, SB 203580, quantitatively suppresses zymosan-induced arachidonic acid release and cPLA2 phosphorylation on S505.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c91 : 1
stoichiometry:c58 : 1
stoichiometry:c105 : 1
stoichiometry:c92 : 1
m47*m67*0.1
nodelay
--
0
PMID: 10080535 PMA and okadaic acid are strong activators of MAPK leading to cPLA2 phosphorylation. treatment of macrophages with the MAPK kinase (MEK) inhibitor, PD98059 together with the p38 inhibitor, SB 203580, quantitatively suppresses zymosan-induced arachidonic acid release and cPLA2 phosphorylation on S505.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c10 : 1
stoichiometry:c11 : 1
m68*m5*0.1
nodelay
--
0
PMID: 10080535 calcium ionophore A23187 is sufficient for cPLA2 activation and arachidonic acid release.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c96 : 1
stoichiometry:c62 : 1
stoichiometry:c97 : 1
m5*m66*0.1
nodelay
--
0
PMID: 10080535 Okadaic acid preferentially induces an increase in phosphorylation on S727.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c67 : 1
stoichiometry:c13 : 1
m5*m6*0.1
nodelay
--
0
PMID: 10080535 cPLA2 can be fully activated by both an increase in intracellular calcium, which drives its translocation to membrane, and phosphorylation on S505.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c18 : 1
stoichiometry:c100 : 1
stoichiometry:c59 : 1
m24*m70*0.1
nodelay
--
0
PMID: 10080535, 8751717 Free arachidonic acid can be metabolized by 5-lipoxygenase (5-LO) or cyclooxygenases 1 and 2 (COX1 and COX2) to generate numerous lipid mediators, such as prostaglandins (PG), leukotrienes (LT),
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c23 : 1
stoichiometry:c21 : 1
stoichiometry:c27 : 1
m29*m24*0.1
nodelay
--
0
PMID: 10080535, 8751717 Free arachidonic acid can be metabolized by 5-lipoxygenase (5-LO) or cyclooxygenases 1 and 2 (COX1 and COX2) to generate numerous lipid mediators, such as prostaglandins (PG), leukotrienes (LT),
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
m25*0.1
nodelay
--
0
PMID: 10080535 Some lysophospholipids,such as lysophosphatidic acid (lyso-PA), can also mediate cellular activation, and alkyl-lysophosphatidylcholine (lyso-PAF) can be acetylated to produce plateletactivating factor (PAF)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c22 : 1
stoichiometry:c29 : 1
m31*m24*0.1
nodelay
--
0
PMID: 10080535, 8751717 Free arachidonic acid can be metabolized by 5-lipoxygenase (5-LO) or cyclooxygenases 1 and 2 (COX1 and COX2) to generate numerous lipid mediators, such as prostaglandins (PG), leukotrienes (LT),
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--